Andreia Melo Porcari
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Andreia Melo Porcari has a total of 257 co-authors. Here are the top co-authors by number of shared publications:
- Alex Aparecido Rosini Silva
Faculdade de Medicina da Universidade Municipal de São Caetano do Sul, São Caetano do Sul, Brazil
20 shared publications - Pedro Henrique Godoy Sanches
Health Sciences Postgraduate Program, São Francisco University, Bragança Paulista Campus, Av. São Francisco de Assis, 218, Bragança Paulista 12916-900, SP, Brazil
11 shared publications - Marcos Nogueira Eberlin
ThoMSon Mass Spectrometry Laboratory, Institute of Chemistry, University of Campinas, Campinas, Sao Paulo, 13083-970, Brazil
10 shared publications - Patrícia de Oliveira Carvalho
Health Sciences Postgraduate Program, Universidade São Francisco (USF), Bragança Paulista 12916-900, SP, Brazil
8 shared publications - Livia Schiavinato Eberlin
Department of Surgery, Baylor College of Medicine, Houston, USA
7 shared publications - Alessandra Tata
Istituto Zooprofilattico Sperimentale Delle Venezie, Laboratorio di Chimica Sperimentale, Vicenza, Italy
6 shared publications
Latest Publications
- Open Access
- 8 June 2026
- Published by Springer Nature in Hormones
- Vol. 25 (2) , 489-503
Effects of melatonin on muscle and liver bioenergetic profiles: focus on acylcarnitines following endurance swimming exercise in rats
Introduction: Melatonin (N-acetyl-5-methoxytryptamine) plays a key role in lipid metabolism regulation, directly influencing fatty acid oxidation and lipid transport and modulating pathways related to energy homeostasis. Objective: This study aimed to evaluate its acute effects on tissue bioenergetics during post-exercise recovery. Methods: Thirty Wistar rats performed a 60-min swimming at 90% of their individual maximal aerobic capacity and received melatonin (10 mg.kg - ¹) or vehicle immediately after exercise. The animals were euthanized at 1, 3, or 24 h post-exercise. Results: Melatonin did not alter the acylcarnitine pool in the muscle or liver, indicating no synergistic effect on β-oxidation. However, it significantly reduced serum glucose levels (F = 11.01; p < 0.001), increased glycogen levels in the red gastrocnemius (F = 82.81; p < 0.001), gluteus maximus (F = 19.55; p < 0.001), and liver (F = 6.24; p < 0.001), and decreased triglyceride content in several skeletal muscles. The integrated biomarker response (IBR) revealed time-dependent shifts in specific acylcarnitine species, although melatonin did not influence these shifts. Conclusion: In conclusion, despite not modulating the acylcarnitine pool, melatonin induced favorable metabolic adaptations by enhancing glycogen replenishment and altering lipid availability in a tissue-specific manner. These findings suggest that melatonin may favor the transport or utilization of larger fatty acid molecules, potentially bypassing the conventional acylcarnitine-mediated oxidation pathways. This highlights its role as a modulator of post-exercise recovery and underscores the need for temporally resolved analyses to unravel its bioenergetic effects.
- 8 June 2026
- Published by Springer Nature in Hormones
- Vol. 25 (2) , 489-503
Open AccessEffects of melatonin on muscle and liver bioenergetic profiles: focus on acylcarnitines following endurance swimming exercise in rats
Introduction: Melatonin (N-acetyl-5-methoxytryptamine) plays a key role in lipid metabolism regulation, directly influencing fatty acid oxidation and lipid transport and modulating pathways related to energy homeostasis. Objective: This study aimed to evaluate its acute effects on tissue bioenergetics during post-exercise recovery. Methods: Thirty Wistar rats performed a 60-min swimming at 90% of their individual maximal aerobic capacity and received melatonin (10 mg.kg - ¹) or vehicle immediately after exercise. The animals were euthanized at 1, 3, or 24 h post-exercise. Results: Melatonin did not alter the acylcarnitine pool in the muscle or liver, indicating no synergistic effect on β-oxidation. However, it significantly reduced serum glucose levels (F = 11.01; p < 0.001), increased glycogen levels in the red gastrocnemius (F = 82.81; p < 0.001), gluteus maximus (F = 19.55; p < 0.001), and liver (F = 6.24; p < 0.001), and decreased triglyceride content in several skeletal muscles. The integrated biomarker response (IBR) revealed time-dependent shifts in specific acylcarnitine species, although melatonin did not influence these shifts. Conclusion: In conclusion, despite not modulating the acylcarnitine pool, melatonin induced favorable metabolic adaptations by enhancing glycogen replenishment and altering lipid availability in a tissue-specific manner. These findings suggest that melatonin may favor the transport or utilization of larger fatty acid molecules, potentially bypassing the conventional acylcarnitine-mediated oxidation pathways. This highlights its role as a modulator of post-exercise recovery and underscores the need for temporally resolved analyses to unravel its bioenergetic effects.
- Open Access
- 16 April 2026
- Published by Springer Nature in Biological Trace Element Research
- Vol. 204 (8) , 1-17
Low-level Blood Multiple Metals Exposure from Informal Jewelry Welding Alters Metabolomic and Lipidomic Profiles in Brazilian Women
Occupational exposure to toxic and potentially toxic elements (PTEs) remains a significant public health concern due to its potential to disrupt human metabolic processes. This study investigated metabolic and lipidomic alterations associated with blood PTE levels in Brazilian women engaged in informal, home-based jewelry welding. A total of 64 participants were included: a welder group ( n = 36) and a control group ( n = 28). Blood PTE concentrations were quantified using inductively coupled plasma mass spectrometry (ICP-MS), and plasma metabolites were profiled using untargeted MS-based metabolomics. Significant between-group differences were observed for arsenic (As; p = 0.01), cadmium (Cd; p = 0.01), and lead (Pb; p < 0.001). Overall, 190 metabolites and 35 lipids were identified at MS¹ and MS² levels. Of these, 53 metabolites and 11 lipids exhibited significant correlations with PTE levels, including phenylalanine (Pb, Cd), acetylcarnitine (As), Sudan I (Cd), hexyl glucoside (Cd, Pb), and MG 22:5 (As, Pb). Enrichment analysis revealed alterations in purine and porphyrin metabolism in the metabolomics dataset, whereas lipidomics indicated disruptions in glycerolipid metabolism, dietary lipid digestion, and ABC transporter-related pathways. Notably, these associations were observed even at low blood PTE levels, indicating biologically relevant molecular alterations and underscoring the need for improved occupational protections in informal working environments.
- 16 April 2026
- Published by Springer Nature in Biological Trace Element Research
- Vol. 204 (8) , 1-17
Open AccessLow-level Blood Multiple Metals Exposure from Informal Jewelry Welding Alters Metabolomic and Lipidomic Profiles in Brazilian Women
Occupational exposure to toxic and potentially toxic elements (PTEs) remains a significant public health concern due to its potential to disrupt human metabolic processes. This study investigated metabolic and lipidomic alterations associated with blood PTE levels in Brazilian women engaged in informal, home-based jewelry welding. A total of 64 participants were included: a welder group ( n = 36) and a control group ( n = 28). Blood PTE concentrations were quantified using inductively coupled plasma mass spectrometry (ICP-MS), and plasma metabolites were profiled using untargeted MS-based metabolomics. Significant between-group differences were observed for arsenic (As; p = 0.01), cadmium (Cd; p = 0.01), and lead (Pb; p < 0.001). Overall, 190 metabolites and 35 lipids were identified at MS¹ and MS² levels. Of these, 53 metabolites and 11 lipids exhibited significant correlations with PTE levels, including phenylalanine (Pb, Cd), acetylcarnitine (As), Sudan I (Cd), hexyl glucoside (Cd, Pb), and MG 22:5 (As, Pb). Enrichment analysis revealed alterations in purine and porphyrin metabolism in the metabolomics dataset, whereas lipidomics indicated disruptions in glycerolipid metabolism, dietary lipid digestion, and ABC transporter-related pathways. Notably, these associations were observed even at low blood PTE levels, indicating biologically relevant molecular alterations and underscoring the need for improved occupational protections in informal working environments.
- Open Access
- 2 April 2026
- Published by Elsevier in SSRN Electronic Journal
Annexin A1 at the Interface of Immunometabolism and Vaginal Tissue Homeostasis in Menopause
Menopause is associated with hormonal, metabolic, and inflammatory changes that contribute to mucosal atrophy and impaired tissue homeostasis, particularly in the vagina. Despite its clinical relevance, the immunometabolic mechanisms underlying menopausal vaginal dysfunction remain poorly understood. Annexin A1 (AnxA1) is an endogenous anti-inflammatory mediator involved in immune regulation and metabolic homeostasis, but its role in menopausal vaginal alterations remains unexplored. We investigated the effects of menopause on vaginal structure, inflammation, and metabolism, and evaluated the contribution of endogenous AnxA1 using wild-type and AnxA1-deficient (AnxA1-/-) mice subjected to 4-vinylcyclohexene diepoxide (VCD)–induced menopause. Vaginal morphology, collagen remodeling, oxidative stress, systemic leukocyte profiles, inflammasome signaling, cytokine production, and untargeted metabolomic profiles of plasma and vaginal tissue were analyzed. VCD-induced menopause promoted vaginal epithelial atrophy, lamina propria thinning, and collagen remodeling, effects that were exacerbated in AnxA1-/- mice. Menopause also increased vaginal reactive oxygen species and altered systemic leukocyte profiles. At the molecular level, menopause enhanced NLRP3 inflammasome signaling and disrupted local cytokine balance, particularly in the absence of AnxA1. Metabolomic analyses revealed pronounced systemic and local metabolic remodeling, with genotype-dependent alterations involving amino acid, lipid, redox, nitrogen, and steroid hormone metabolism. Pathway enrichment analyses identified distinct immunometabolic adaptations in plasma and vaginal tissue, with AnxA1 deficiency amplifying disturbances in nitrogen metabolism, redox homeostasis, and lipid-derived inflammatory pathways. Together, these findings demonstrate that menopause drives immunometabolic remodeling of vaginal tissue and identify AnxA1 as a key endogenous regulator of vaginal homeostasis during the menopausal transition, highlighting AnxA1-related pathways as potential non-hormonal therapeutic targets.
- 2 April 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessAnnexin A1 at the Interface of Immunometabolism and Vaginal Tissue Homeostasis in Menopause
Menopause is associated with hormonal, metabolic, and inflammatory changes that contribute to mucosal atrophy and impaired tissue homeostasis, particularly in the vagina. Despite its clinical relevance, the immunometabolic mechanisms underlying menopausal vaginal dysfunction remain poorly understood. Annexin A1 (AnxA1) is an endogenous anti-inflammatory mediator involved in immune regulation and metabolic homeostasis, but its role in menopausal vaginal alterations remains unexplored. We investigated the effects of menopause on vaginal structure, inflammation, and metabolism, and evaluated the contribution of endogenous AnxA1 using wild-type and AnxA1-deficient (AnxA1-/-) mice subjected to 4-vinylcyclohexene diepoxide (VCD)–induced menopause. Vaginal morphology, collagen remodeling, oxidative stress, systemic leukocyte profiles, inflammasome signaling, cytokine production, and untargeted metabolomic profiles of plasma and vaginal tissue were analyzed. VCD-induced menopause promoted vaginal epithelial atrophy, lamina propria thinning, and collagen remodeling, effects that were exacerbated in AnxA1-/- mice. Menopause also increased vaginal reactive oxygen species and altered systemic leukocyte profiles. At the molecular level, menopause enhanced NLRP3 inflammasome signaling and disrupted local cytokine balance, particularly in the absence of AnxA1. Metabolomic analyses revealed pronounced systemic and local metabolic remodeling, with genotype-dependent alterations involving amino acid, lipid, redox, nitrogen, and steroid hormone metabolism. Pathway enrichment analyses identified distinct immunometabolic adaptations in plasma and vaginal tissue, with AnxA1 deficiency amplifying disturbances in nitrogen metabolism, redox homeostasis, and lipid-derived inflammatory pathways. Together, these findings demonstrate that menopause drives immunometabolic remodeling of vaginal tissue and identify AnxA1 as a key endogenous regulator of vaginal homeostasis during the menopausal transition, highlighting AnxA1-related pathways as potential non-hormonal therapeutic targets.
- Open Access
- 17 July 2025
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 10 (29) , 31313-31330
Nutritional Supplementation Benefits in Caenorhabditis elegans under Developmental Disruption and Stress Conditions
Autism spectrum disorder (ASD) is a developmental and neurological condition that impacts an individual's behavior, communication, social interaction, and learning abilities. This disease is complex and involves different mechanisms, and therefore, modeling is a major challenge. Some features can be reproduced in different animal models to investigate therapeutic approaches. Here, we proposed a new simple model to induce development delay by using the nematode and dithiothreitol (DTT) as a chemical agent. In order to investigate a complementary treatment, a commercial supplement and its isolated components (vit. B12, B1, B6, and B9), curcumin, and palmitoylethanolamide (PEA) were used to revert the oxidative stress, development impairments, and metabolomic changes caused by DTT. Furthermore, computational tools predicted pharmacokinetic properties (SwissADME) and possible pathways (enrichment analysis) linked to ASD, an important neurodevelopmental disorder. The supplement and its components (curcumin, PEA, vit. B12, B6, and B9) partially alleviated the delay in larval progression and completely recovered the GABAergic neurodevelopmental impairments (supplement, curcumin, vit. B6, B9, and B12) caused by DDT. Vitamin B9, B12, and supplement partially protected mortality against the oxidative stressor Paraquat. Curcumin, vit. B1, B6, and supplement showed potential protection against coexposure to DTT by reducing DAF-16 migration to the nucleus compared to DTT. Vitamins B1, B9, and B12 coexposure to DTT positively modulated SOD-3 expression. Amino acids, carnitines, and lipids revealed by LC-MS analysis enabled group differentiation and pathway analysis, indicating potential signaling molecules. In silico analysis predicted that these components may interact with pathways linked to ASD pathogenesis such as immunomodulation, synaptic pruning, and complex behavior regulation. Our data indicate that DTT is a good chemical model to induce developmental disorders and that the supplement, with all its components associated, is a promising therapy to be investigated in ASD.
- 17 July 2025
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 10 (29) , 31313-31330
Open AccessNutritional Supplementation Benefits in Caenorhabditis elegans under Developmental Disruption and Stress Conditions
Autism spectrum disorder (ASD) is a developmental and neurological condition that impacts an individual's behavior, communication, social interaction, and learning abilities. This disease is complex and involves different mechanisms, and therefore, modeling is a major challenge. Some features can be reproduced in different animal models to investigate therapeutic approaches. Here, we proposed a new simple model to induce development delay by using the nematode and dithiothreitol (DTT) as a chemical agent. In order to investigate a complementary treatment, a commercial supplement and its isolated components (vit. B12, B1, B6, and B9), curcumin, and palmitoylethanolamide (PEA) were used to revert the oxidative stress, development impairments, and metabolomic changes caused by DTT. Furthermore, computational tools predicted pharmacokinetic properties (SwissADME) and possible pathways (enrichment analysis) linked to ASD, an important neurodevelopmental disorder. The supplement and its components (curcumin, PEA, vit. B12, B6, and B9) partially alleviated the delay in larval progression and completely recovered the GABAergic neurodevelopmental impairments (supplement, curcumin, vit. B6, B9, and B12) caused by DDT. Vitamin B9, B12, and supplement partially protected mortality against the oxidative stressor Paraquat. Curcumin, vit. B1, B6, and supplement showed potential protection against coexposure to DTT by reducing DAF-16 migration to the nucleus compared to DTT. Vitamins B1, B9, and B12 coexposure to DTT positively modulated SOD-3 expression. Amino acids, carnitines, and lipids revealed by LC-MS analysis enabled group differentiation and pathway analysis, indicating potential signaling molecules. In silico analysis predicted that these components may interact with pathways linked to ASD pathogenesis such as immunomodulation, synaptic pruning, and complex behavior regulation. Our data indicate that DTT is a good chemical model to induce developmental disorders and that the supplement, with all its components associated, is a promising therapy to be investigated in ASD.
- Open Access
- 27 March 2025
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 73 (14) , 8160-8171
Herbicidal Activity and Metabolic Profiling of Piper tuberculatum Jacq. Leachates
Understanding how allelochemicals with herbicidal activity are released in plant interactions is key to developing sustainable weed control strategies. This study aimed to investigate the herbicidal activity and metabolic profile of Piper tuberculatum Jacq. leachates. In vitro bioassays were performed with P. tuberculatum leaf leachates to evaluate their effects on the germination and early growth of Bidens bipinnata L. and Digitaria insularis (L.) Fedde. (DIGIN.). The leachate extracts were subsequently characterized via liquid chromatography high-resolution mass spectrometry-based metabolomics and molecular networking. The results showed that weed germination and seedling development were significantly affected by the P. tuberculatum leachates. Metabolomic analysis revealed that allelochemicals belonging to the classes of alkaloids, fatty acids, phenolic compounds, steroids, and terpenoids are potentially involved in herbicidal activity. These findings suggest that P. tuberculatum could be explored as a natural alternative for sustainable weed management, potentially reducing the dependence on synthetic herbicides.
- 27 March 2025
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 73 (14) , 8160-8171
Open AccessHerbicidal Activity and Metabolic Profiling of Piper tuberculatum Jacq. Leachates
Understanding how allelochemicals with herbicidal activity are released in plant interactions is key to developing sustainable weed control strategies. This study aimed to investigate the herbicidal activity and metabolic profile of Piper tuberculatum Jacq. leachates. In vitro bioassays were performed with P. tuberculatum leaf leachates to evaluate their effects on the germination and early growth of Bidens bipinnata L. and Digitaria insularis (L.) Fedde. (DIGIN.). The leachate extracts were subsequently characterized via liquid chromatography high-resolution mass spectrometry-based metabolomics and molecular networking. The results showed that weed germination and seedling development were significantly affected by the P. tuberculatum leachates. Metabolomic analysis revealed that allelochemicals belonging to the classes of alkaloids, fatty acids, phenolic compounds, steroids, and terpenoids are potentially involved in herbicidal activity. These findings suggest that P. tuberculatum could be explored as a natural alternative for sustainable weed management, potentially reducing the dependence on synthetic herbicides.
- Open Access
- 2 January 2025
- Published by Taylor & Francis in Journal of Plant Interactions
- Vol. 20 (1)
Effects of shading and water availability on Kalanchoe pinnata (Lam.) Pers. (Crassulaceae) metabolite profile via a LC-MS-based untargeted metabolomics approach
- 2 January 2025
- Published by Taylor & Francis in Journal of Plant Interactions
- Vol. 20 (1)
Open AccessEffects of shading and water availability on Kalanchoe pinnata (Lam.) Pers. (Crassulaceae) metabolite profile via a LC-MS-based untargeted metabolomics approach
- 1 January 2025
- Published by Sociedade Brasileira de Quimica (SBQ) in Journal of the Brazilian Chemical Society
- Vol. 36 (4)
Determination of Lisdexamfetamine in Human Plasma by LC-MS/MS Method
Lisdexamfetamine is a prodrug that is converted to d-amphetamine in the body, mainly used to treat attention deficit hyperactivity disorder in children and adults. Its mechanism involves the enhancement of neurotransmitters such as norepinephrine and dopamine, which are critical for attention and behavioral regulation. With the upcoming patent expiration of Vyvanse®, bioanalytical methods for the quantification of lisdexamfetamine in plasma are needed for use in pharmacokinetic studies. In this work, we developed and validated a sensitive bioanalytical method using liquid chromatography-tandem mass spectrometry (LC-MS/MS) for lisdexamfetamine quantification in human plasma. The method developed was performed for 4 min per sample and using the concentration range of 0.3-100 ng mL-1. Intra-batch, inter-batch and instrument reproducibility, the precision was lower than 10%. The results demonstrated that the method is rapid, sensitive, robust, and suitable for pharmacokinetic studies.
- 1 January 2025
- Published by Sociedade Brasileira de Quimica (SBQ) in Journal of the Brazilian Chemical Society
- Vol. 36 (4)
Determination of Lisdexamfetamine in Human Plasma by LC-MS/MS Method
Lisdexamfetamine is a prodrug that is converted to d-amphetamine in the body, mainly used to treat attention deficit hyperactivity disorder in children and adults. Its mechanism involves the enhancement of neurotransmitters such as norepinephrine and dopamine, which are critical for attention and behavioral regulation. With the upcoming patent expiration of Vyvanse®, bioanalytical methods for the quantification of lisdexamfetamine in plasma are needed for use in pharmacokinetic studies. In this work, we developed and validated a sensitive bioanalytical method using liquid chromatography-tandem mass spectrometry (LC-MS/MS) for lisdexamfetamine quantification in human plasma. The method developed was performed for 4 min per sample and using the concentration range of 0.3-100 ng mL-1. Intra-batch, inter-batch and instrument reproducibility, the precision was lower than 10%. The results demonstrated that the method is rapid, sensitive, robust, and suitable for pharmacokinetic studies.
- Open Access
Combined Association of Plasma Metabolites with Body Mass Index and Physical Activity Level
Metabolomic analysis of the changes in plasma metabolites in obesity along with physical activity interaction may contribute to disease diagnosis and treatment. We sought to make a comprehensive assessment of the plasma metabolite profile of subjects with a lean (n = 20, BMI = 22.3) or overweight/obese (n = 29, BMI = 29) body mass index (BMI) and low (n = 33, IPAQ = 842) or high (n = 16, IPAQ = 6935) index of physical activity questionnaire (IPAQ), using an untargeted metabolomic approach. Two-way analysis of variance was applied to the data obtained from liquid chromatography–mass spectrometry analyses and resulted in 64 metabolites, mainly responsible for the data variance among the different groups. Finally, a complex network approach reveals the most relevant metabolites. The majority of the relevant metabolites are oxidized species of phospholipids. Most species of phosphatidylcholine and a species of phosphatidylglycerol were found to be decreased in obese subjects, while most species of phosphatidylethanolamine, phosphatidylserine, and phosphatidylinositol were increased. Only a single species each of prostaglandin, phosphatidylglycerol, and phosphatidylinositol were modulated by IPAQ, but interaction effects between BMI and IPAQ were found for most of the metabolites in the combination of obese BMI with low IPAQ.
Open AccessCombined Association of Plasma Metabolites with Body Mass Index and Physical Activity Level
Metabolomic analysis of the changes in plasma metabolites in obesity along with physical activity interaction may contribute to disease diagnosis and treatment. We sought to make a comprehensive assessment of the plasma metabolite profile of subjects with a lean (n = 20, BMI = 22.3) or overweight/obese (n = 29, BMI = 29) body mass index (BMI) and low (n = 33, IPAQ = 842) or high (n = 16, IPAQ = 6935) index of physical activity questionnaire (IPAQ), using an untargeted metabolomic approach. Two-way analysis of variance was applied to the data obtained from liquid chromatography–mass spectrometry analyses and resulted in 64 metabolites, mainly responsible for the data variance among the different groups. Finally, a complex network approach reveals the most relevant metabolites. The majority of the relevant metabolites are oxidized species of phospholipids. Most species of phosphatidylcholine and a species of phosphatidylglycerol were found to be decreased in obese subjects, while most species of phosphatidylethanolamine, phosphatidylserine, and phosphatidylinositol were increased. Only a single species each of prostaglandin, phosphatidylglycerol, and phosphatidylinositol were modulated by IPAQ, but interaction effects between BMI and IPAQ were found for most of the metabolites in the combination of obese BMI with low IPAQ.
- Open Access
- 13 November 2024
- Published by MDPI AG in Biomedicines
- Vol. 12 (11) , 2593
Tumor-Promoted Changes in Pediatric Brain Histology Can Be Distinguished from Normal Parenchyma by Desorption Electrospray Ionization Mass Spectrometry Imaging
Background: Central nervous system (CNS) tumors are the second most frequent type of neoplasm in childhood and adolescence, after leukemia. Despite the incorporation of molecular classification and improvement of protocols combining chemotherapy, surgery, and radiotherapy, CNS tumors are still the most lethal neoplasm in this age group. Mass spectrometry imaging (MSI) is a powerful tool to map the distribution of molecular species in tissue sections. Among MSI techniques, desorption electrospray ionization (DESI-MSI) has been demonstrated to enable reliable agreement with the pathological evaluation of different adult cancer types, along with an acceptable time scale for intraoperative use. Methods: In the present work, we aimed to investigate the chemical profile obtained by DESI-MSI as an intraoperative surgical management tool by profiling 162 pediatric brain biopsies and reporting the results according to the histopathology and molecular profile of the tumors. Results: The 2D chemical images obtained by DESI-MSI allowed us to distinguish tumor-transformed tissue from non-tumor tissue with an accuracy of 96.8% in the training set and 94.3% in the validation set after statistical modeling of our data using Lasso. In addition, high-grade and low-grade tumors also displayed a distinct chemical profile when analyzed by DESI-MSI. We also provided evidence that the chemical profile of brain tumors obtained by DESI-MSI correlates with methylation-based molecular classes and specific immunophenotypes found in brain biopsies. Conclusions: The results presented herein support the incorporation of DESI-MSI analysis as an intraoperative assistive tool in prospective clinical trials for pediatric brain tumors management in the near future.
- 13 November 2024
- Published by MDPI AG in Biomedicines
- Vol. 12 (11) , 2593
Open AccessTumor-Promoted Changes in Pediatric Brain Histology Can Be Distinguished from Normal Parenchyma by Desorption Electrospray Ionization Mass Spectrometry Imaging
Background: Central nervous system (CNS) tumors are the second most frequent type of neoplasm in childhood and adolescence, after leukemia. Despite the incorporation of molecular classification and improvement of protocols combining chemotherapy, surgery, and radiotherapy, CNS tumors are still the most lethal neoplasm in this age group. Mass spectrometry imaging (MSI) is a powerful tool to map the distribution of molecular species in tissue sections. Among MSI techniques, desorption electrospray ionization (DESI-MSI) has been demonstrated to enable reliable agreement with the pathological evaluation of different adult cancer types, along with an acceptable time scale for intraoperative use. Methods: In the present work, we aimed to investigate the chemical profile obtained by DESI-MSI as an intraoperative surgical management tool by profiling 162 pediatric brain biopsies and reporting the results according to the histopathology and molecular profile of the tumors. Results: The 2D chemical images obtained by DESI-MSI allowed us to distinguish tumor-transformed tissue from non-tumor tissue with an accuracy of 96.8% in the training set and 94.3% in the validation set after statistical modeling of our data using Lasso. In addition, high-grade and low-grade tumors also displayed a distinct chemical profile when analyzed by DESI-MSI. We also provided evidence that the chemical profile of brain tumors obtained by DESI-MSI correlates with methylation-based molecular classes and specific immunophenotypes found in brain biopsies. Conclusions: The results presented herein support the incorporation of DESI-MSI analysis as an intraoperative assistive tool in prospective clinical trials for pediatric brain tumors management in the near future.
- Open Access
- 6 November 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (22)
Mass Spectrometry-Based Metabolomics Reveals a Salivary Signature for Low-Severity COVID-19
Omics approaches were extensively applied during the coronavirus disease 2019 (COVID-19) pandemic to understand the disease, identify biomarkers with diagnostic and prognostic value, and discover new molecular targets for medications. COVID-19 continues to challenge the healthcare system as the virus mutates, becoming more transmissible or adept at evading the immune system, causing resurgent epidemic waves over the last few years. In this study, we used saliva from volunteers who were negative and positive for COVID-19 when Omicron and its variants became dominant. We applied a direct solid-phase extraction approach followed by non-target metabolomics analysis to identify potential salivary signatures of hospital-recruited volunteers to establish a model for COVID-19 screening. Our model, which aimed to differentiate COVID-19-positive individuals from controls in a hospital setting, was based on 39 compounds and achieved high sensitivity (85%/100%), specificity (82%/84%), and accuracy (84%/92%) in training and validation sets, respectively. The salivary diagnostic signatures were mainly composed of amino acids and lipids and were related to a heightened innate immune antiviral response and an attenuated inflammatory profile. The higher abundance of thyrotropin-releasing hormone in the COVID-19 positive group highlighted the endocrine imbalance in low-severity disease, as first reported here, underscoring the need for further studies in this area.
- 6 November 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (22)
Open AccessMass Spectrometry-Based Metabolomics Reveals a Salivary Signature for Low-Severity COVID-19
Omics approaches were extensively applied during the coronavirus disease 2019 (COVID-19) pandemic to understand the disease, identify biomarkers with diagnostic and prognostic value, and discover new molecular targets for medications. COVID-19 continues to challenge the healthcare system as the virus mutates, becoming more transmissible or adept at evading the immune system, causing resurgent epidemic waves over the last few years. In this study, we used saliva from volunteers who were negative and positive for COVID-19 when Omicron and its variants became dominant. We applied a direct solid-phase extraction approach followed by non-target metabolomics analysis to identify potential salivary signatures of hospital-recruited volunteers to establish a model for COVID-19 screening. Our model, which aimed to differentiate COVID-19-positive individuals from controls in a hospital setting, was based on 39 compounds and achieved high sensitivity (85%/100%), specificity (82%/84%), and accuracy (84%/92%) in training and validation sets, respectively. The salivary diagnostic signatures were mainly composed of amino acids and lipids and were related to a heightened innate immune antiviral response and an attenuated inflammatory profile. The higher abundance of thyrotropin-releasing hormone in the COVID-19 positive group highlighted the endocrine imbalance in low-severity disease, as first reported here, underscoring the need for further studies in this area.